Related Experiment Video
Updated: Apr 20, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Virology and cell biology of the hepatitis C virus life cycle: an update
Jean Dubuisson1, François-Loïc Cosset2
1Institut Pasteur de Lille, Center for Infection & Immunity of Lille (CIIL), F-59019 Lille, France; CNRS UMR8204, F-59021 Lille, France; Inserm U1019, F-59019 Lille, France; Université Lille Nord de France, F-59000 Lille, France.
Insights
Hepatitis C virus (HCV) infection causes liver disease and cancer. New antiviral treatments are emerging, improving understanding of the HCV life cycle and host interactions for better therapies.
Area of Science:
- Virology
- Hepatology
- Public Health
Background:
- Hepatitis C virus (HCV) is a major global health concern, leading to liver cirrhosis and cancer.
- Chronic HCV infection rates are projected to rise, increasing the burden of progressive liver disease.
- Current antiviral therapies are transforming hepatitis C treatment paradigms.
Purpose of the Study:
- To review recent advancements in understanding the Hepatitis C virus (HCV) life cycle.
- To explore the intricate interactions between HCV and host factors.
- To highlight progress in identifying new anti-HCV therapeutic targets.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies on HCV replication and pathogenesis.
- Synthesis of data on host-pathogen interactions in HCV infection.
Main Results:
- Significant progress has been made in elucidating the various stages of the HCV life cycle.
- Key host factors and pathways crucial for HCV replication have been identified.
- New antiviral strategies are being developed based on this enhanced knowledge.
Conclusions:
- Continued research into the HCV life cycle and host interactions is vital for developing effective treatments.
- The evolving landscape of hepatitis C treatment offers hope for managing this global health challenge.
- Understanding viral-host dynamics is crucial for future therapeutic interventions against HCV.
Abstract:
Hepatitis C virus (HCV) is an important human pathogen that causes hepatitis, liver cirrhosis and hepatocellular carcinoma. It imposes a serious problem to public health in the world as the population of chronically infected HCV patients who are at risk of progressive liver disease is projected to increase significantly in the next decades. However, the arrival of new antiviral molecules is progressively changing the landscape of hepatitis C treatment. The search for new anti-HCV therapies has also been a driving force to better understand how HCV interacts with its host, and major progresses have been made on the various steps of the HCV life cycle. Here, we review the most recent advances in the fast growing knowledge on HCV life cycle and interaction with host factors and pathways.
Related Concept Videos
Hepatitis
Retrovirus Life Cycles
What are Viruses?
Viruses with RNA Genomes
Viral Hepatitis I: Introduction
Viral Replication: Lytic Cycle

